Brokerages Set UiPath Inc. (NYSE:PATH) Price Target at $27.41

Shares of UiPath Inc. (NYSE:PATHGet Free Report) have received a consensus rating of “Moderate Buy” from the eighteen analysts that are currently covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $27.41.

A number of research analysts have recently weighed in on PATH shares. DA Davidson raised their price objective on UiPath from $20.00 to $24.00 and gave the company a “neutral” rating in a research report on Thursday, March 14th. JPMorgan Chase & Co. upgraded UiPath from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $22.00 to $28.00 in a research report on Thursday, March 14th. Evercore ISI raised their price objective on UiPath from $24.00 to $27.00 and gave the company an “in-line” rating in a research report on Thursday, March 14th. Bank of America boosted their price objective on UiPath from $26.00 to $30.00 and gave the stock a “buy” rating in a research note on Thursday, March 14th. Finally, BMO Capital Markets raised their price objective on UiPath from $24.00 to $28.00 and gave the company a “market perform” rating in a research note on Thursday, March 14th.

View Our Latest Report on UiPath

Insider Buying and Selling at UiPath

In other news, CFO Ashim Gupta sold 40,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the transaction, the chief financial officer now directly owns 660,762 shares of the company’s stock, valued at $14,312,104.92. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 31.03% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On UiPath

A number of hedge funds and other institutional investors have recently made changes to their positions in PATH. Mark Sheptoff Financial Planning LLC purchased a new stake in UiPath in the fourth quarter worth about $25,000. HighMark Wealth Management LLC bought a new position in shares of UiPath during the fourth quarter valued at approximately $27,000. ORG Partners LLC boosted its stake in shares of UiPath by 875.6% during the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after purchasing an additional 1,112 shares in the last quarter. Cypress Capital Management LLC WY bought a new position in shares of UiPath during the fourth quarter valued at approximately $29,000. Finally, Fifth Third Bancorp boosted its stake in shares of UiPath by 2,005.3% during the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock valued at $34,000 after purchasing an additional 1,905 shares in the last quarter. Institutional investors own 62.50% of the company’s stock.

UiPath Stock Up 1.8 %

NYSE:PATH opened at $19.84 on Friday. The business’s 50-day simple moving average is $21.75 and its two-hundred day simple moving average is $21.72. The stock has a market cap of $11.29 billion, a PE ratio of -116.40 and a beta of 1.01. UiPath has a 52 week low of $12.89 and a 52 week high of $27.87.

UiPath (NYSE:PATHGet Free Report) last posted its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. The business had revenue of $405.25 million for the quarter, compared to analysts’ expectations of $383.32 million. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. Sell-side analysts anticipate that UiPath will post -0.04 earnings per share for the current fiscal year.

UiPath Company Profile

(Get Free Report

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

Analyst Recommendations for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.